Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
QuintilesIMS
AstraZeneca
Covington
Chinese Patent Office
Dow
Merck
Cipla
Daiichi Sankyo
Fish and Richardson

Generated: October 23, 2017

DrugPatentWatch Database Preview

CORZIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Corzide, and what generic Corzide alternatives are available?

Corzide is a drug marketed by King Pharms Llc and is included in one NDA.

The generic ingredient in CORZIDE is bendroflumethiazide; nadolol. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the bendroflumethiazide; nadolol profile page.

Summary for Tradename: CORZIDE

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list33
Clinical Trials: see list2
Patent Applications: see list1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CORZIDE at DailyMed

Pharmacology for Tradename: CORZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
King Pharms Llc
CORZIDE
bendroflumethiazide; nadolol
TABLET;ORAL018647-001May 25, 1983ABRXYesNo► Subscribe► Subscribe► Subscribe
King Pharms Llc
CORZIDE
bendroflumethiazide; nadolol
TABLET;ORAL018647-002May 25, 1983ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: CORZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
King Pharms Llc
CORZIDE
bendroflumethiazide; nadolol
TABLET;ORAL018647-001May 25, 1983► Subscribe► Subscribe
King Pharms Llc
CORZIDE
bendroflumethiazide; nadolol
TABLET;ORAL018647-002May 25, 1983► Subscribe► Subscribe
King Pharms Llc
CORZIDE
bendroflumethiazide; nadolol
TABLET;ORAL018647-001May 25, 1983► Subscribe► Subscribe
King Pharms Llc
CORZIDE
bendroflumethiazide; nadolol
TABLET;ORAL018647-002May 25, 1983► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Chinese Patent Office
Chubb
Teva
Julphar
Farmers Insurance
Federal Trade Commission
Covington
US Department of Justice
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot